COc1ccccc1CNC(=O)C(C)n1c(=O)cc(C(F)(F)F)c2c(C)nn(C)c21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?